Chronic disease treatment advances add to U.S. health care bill

Advances in treatments for diabetes and many other chronic illnesses may have reduced hospitalizations, but their cost may be even higher than that of treating acute events. The few makers of supplies and drugs for Type 1 diabetes have considerable market power, and doctors say some advances, such as "talking" blood glucose meters, are not worth the cost.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA